Back to top

Analyst Blog

This page is temporarily not available.  Please check later as it should be available shortly. If you have any questions, please email customer support at support@zacks.com or call 800-767-3771 ext.  9339.

PerkinElmer, Inc. (PKI - Analyst Report) posted adjusted earnings per share (EPS) of 49 cents in the third quarter of 2013, exceeding the Zacks Consensus Estimate by a penny as well as the year-ago level of 45 cents by 8.9%. Reported figurers are impressive as they depict growth of 44% in EPS to 36 cents from 25 cents a year ago.

Revenues in the quarter inched up 2.9% to $524.3 million and were in line with the Zacks Consensus Estimate. Organic revenues rose 2% in the quarter. Adjusted revenues went up only 2% to $525.1 million while organic revenues grew 2% as well.

Adjusted operating income edged up 4.2% to $81.6 million from $78.3 million in the year-ago quarter. Adjusted operating profit margin increased 30 basis points to 15.5% from 15.2% a year ago.

Segment Results

Revenues from the Human Health segment went up 1.8% to $292.4 million while organic revenues were flat year-over-year. Adjusted operating income rose 4.0% to $65.6 million compared with $63.1 million in the same quarter a year ago. Adjusted operating margin increased 80 bps to 22.4% in the quarter.

Revenues from Environmental Health rose 4.3% to $231.9 million with a 4% increase in organic revenues. Adjusted operating income dipped marginally by 1.6% to $24.5 million from $24.9 million in the third quarter of 2012. Adjusted operating margin ebbed 60 bps to 10.6% compared with the year-ago level.

Financial Position

PerkinElmer had cash and cash equivalents of $132.3 million as of Sep 30, 2013, down from $171.4 million as of Dec 31, 2012. Total debt declined slightly to $935.9 million as of Sep 30, 2013 compared with $940.6 million as of Dec 31, 2012.

In the first nine months of 2013, cash flow from operating activities fell 23.6% to $87.0 million from $113.8 million in the same period of 2012, mainly driven by higher inventories. Adjusted operating cash flow rose 7.7% to $161.8 million from $150.3 million in the first nine months of 2012. Capital expenditure rose 30.0% to $31.6 million compared with $24.4 million a year ago.

2013 Outlook

PerkinElmer continues to expect organic revenue growth in the low-single digit range in the year compared with 2012. PKI narrowed its reported earnings per share guidance to $1.42–$1.45 from the earlier range of $1.40 to $1.47 and adjusted earnings per share to $2.04–$2.07 from $2.03 to $2.10. The current Zacks Consensus Estimate for 2013 is the upper-end of the new guidance.

Our Take

PerkinElmer, Inc. is a global technology company which provides products and systems to the telecom, medical, pharmaceutical, chemical, semiconductor and photographic markets. PKI has operations in over 100 countries, and is a component of the S&P 500 Index. Currently, it retains a Zacks Rank #3 (Hold).

While we remain on the sidelines about PKI, stock that is performing well in the scientific instruments industry include Mettler-Toledo International Inc. (MTD - Snapshot Report) with a Zacks Rank #2 (Buy). Due to lack of any other favorable stocks, we consider CryoLife, Inc. (CRY - Snapshot Report) and Natus Medical Inc. (BABY - Snapshot Report) from the medical instruments industry as worth to look for. Both of them carry a Zacks Rank #1 (Strong Buy).

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

Learn more

Start for as little as $4.50 per trade.

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
GENERAL FINA GFN 8.20 +5.67%
QIHOO 360 TE QIHU 91.57 +4.38%
VIPSHOP HOLD VIPS 140.01 +3.49%
INVESTMENT T ITG 19.16 +3.34%
VERTEX ENERG VTNR 7.38 +3.07%